Description
MIA-602 (GHRH antagonist) — 2 mg, ≥98 % HPLC — research overview
MIA-602 is a synthetic GHRH-receptor antagonist developed by the Schally group and cited in oncology cell-line, proliferation-marker and inflammation-pathway research.
Peptide Shop supplies MIA-602 (1 × 2 mg vial) as a sealed research material with lot-level documentation. This product is supplied for in-vitro laboratory research only and is not intended for human use, veterinary use, therapy, diagnosis, cosmetic application or consumption.
Research applications
- GHRH-receptor antagonist binding and competition assays
- Proliferation-marker and oncology cell-line research
- Inflammation-pathway and lung-cell research models
- Endocrine-oncology mechanism studies
Sequence and analytical data
Highly modified non-natural peptide with multiple D-amino acids and N-terminal acylation; identity confirmed by ESI-MS and amino-acid analysis.
Storage and handling
Store lyophilised at -20 °C. Reconstitute in 0.1% acetic acid or DMSO depending on assay; aliquot and store at -80 °C.
Documentation
A lot-specific Certificate of Analysis is available in EN, DE, FR and ES from the product detail page after dispatch. The CoA reports HPLC purity, identity confirmation, appearance, and storage and handling guidance for the dispatched lot.
